DK2238974T3 - Granulat til formulering af smeltetabletter - Google Patents

Granulat til formulering af smeltetabletter

Info

Publication number
DK2238974T3
DK2238974T3 DK09425135.2T DK09425135T DK2238974T3 DK 2238974 T3 DK2238974 T3 DK 2238974T3 DK 09425135 T DK09425135 T DK 09425135T DK 2238974 T3 DK2238974 T3 DK 2238974T3
Authority
DK
Denmark
Prior art keywords
granules
formulation
orodispersible tablets
orodispersible
tablets
Prior art date
Application number
DK09425135.2T
Other languages
English (en)
Inventor
Massimiliano Rossi
Riccardo Catalano
Silvia Boschetti
Paolo Andreatta
Original Assignee
E Pharma Trento Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40909993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2238974(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by E Pharma Trento Spa filed Critical E Pharma Trento Spa
Application granted granted Critical
Publication of DK2238974T3 publication Critical patent/DK2238974T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DK09425135.2T 2009-04-09 2009-04-09 Granulat til formulering af smeltetabletter DK2238974T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09425135.2A EP2238974B9 (en) 2009-04-09 2009-04-09 Granulate for the formulation of orodispersible tablets

Publications (1)

Publication Number Publication Date
DK2238974T3 true DK2238974T3 (da) 2013-08-26

Family

ID=40909993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09425135.2T DK2238974T3 (da) 2009-04-09 2009-04-09 Granulat til formulering af smeltetabletter

Country Status (10)

Country Link
US (3) US20100260854A1 (da)
EP (1) EP2238974B9 (da)
CA (1) CA2697576C (da)
CY (1) CY1114183T1 (da)
DK (1) DK2238974T3 (da)
ES (1) ES2422281T3 (da)
HR (1) HRP20130805T2 (da)
PL (1) PL2238974T3 (da)
PT (1) PT2238974E (da)
SI (1) SI2238974T1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2422281T3 (es) * 2009-04-09 2013-09-10 E Pharma Trento Spa Granulado para la formulación de comprimidos bucodispersables
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
DE19615418A1 (de) * 1996-04-22 1997-10-23 Merck Patent Gmbh Polyol-Zusammensetzung
ES2263216T3 (es) 1997-07-25 2006-12-01 Alpex Pharma S.A. Procedimiento para la preparacion de un granulado adecuado para la preparacion de comprimidos solubles en la boca rapidamente disgregables.
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
FR2787110B1 (fr) * 1998-12-11 2001-02-16 Roquette Freres Sorbitol pulverulent et son procede de preparation
NZ512166A (en) * 2001-06-01 2003-09-26 Marketing Brokers Nz Ltd Wax applicator with a cylindrical roller having convex ends.
ATE346590T1 (de) 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FI20021312A (fi) * 2002-07-03 2004-01-04 Danisco Sweeteners Oy Polyolikoostumusten kiteyttäminen, kiteinen polyolikoostumustuote ja sen käyttö
PL1799195T3 (pl) * 2004-08-12 2016-09-30 Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału
FR2894475B1 (fr) 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
US20070212417A1 (en) * 2006-03-07 2007-09-13 Cherukuri S R Compressible resilient granules and formulations prepared therefrom
FR2898492B1 (fr) 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
EP2170273B1 (de) * 2007-06-06 2014-11-26 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
ES2422281T3 (es) * 2009-04-09 2013-09-10 E Pharma Trento Spa Granulado para la formulación de comprimidos bucodispersables

Also Published As

Publication number Publication date
EP2238974B1 (en) 2013-06-05
US9861581B2 (en) 2018-01-09
ES2422281T3 (es) 2013-09-10
US10632073B2 (en) 2020-04-28
EP2238974B9 (en) 2014-05-21
PL2238974T3 (pl) 2013-09-30
US20180092849A1 (en) 2018-04-05
PT2238974E (pt) 2013-07-09
CY1114183T1 (el) 2016-08-31
EP2238974A1 (en) 2010-10-13
CA2697576A1 (en) 2010-10-09
US20100260854A1 (en) 2010-10-14
US20160045438A1 (en) 2016-02-18
HRP20130805T1 (en) 2013-09-30
HRP20130805T2 (en) 2013-10-11
SI2238974T1 (sl) 2013-09-30
CA2697576C (en) 2017-07-11

Similar Documents

Publication Publication Date Title
CY2020008I2 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
DK2442791T3 (da) Former til dosering af apixaban
SMT201600249B (it) Composizioni farmaceutiche acquose contenenti complessi borato- poliolo
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
BR112012011733A2 (pt) formulações de comprimido de liberação imediata
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
SMT201400069B (it) Formulazione farmaceutica
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
IT1394860B1 (it) Composti farmaceutici
BRPI1012539A2 (pt) composições farmacêuticas
BRPI1015939A2 (pt) composição farmacêutica
GT201200303A (es) Formulaciones farmacéuticas
IT1394400B1 (it) Composizioni farmaceutiche
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI0921654A2 (pt) formulação farmacêutica
BRPI0912428A2 (pt) formulação farmacêutica sólida de liberação retardada
FR2898492B1 (fr) Comprimes orodispersibles de domperidone
IT1393930B1 (it) Composti farmaceutici
BR112012001340A2 (pt) composições farmacêuticas
BR112012003149A2 (pt) composição farmacêutica
DK2571488T3 (da) Farmaceutisk komposition af ibuprofen til injektion
BRPI0912656A2 (pt) formulação farmacêutica sólida